ctrl K

Price Alert

Monte Rosa Therapeutics I... (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

4.44

0.09 (2.07%)

At close: Aug 15, 2025, 10:05 AM

Monte Rosa Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	224.25M	128.1M	54.91M	346.07M
Short-Term Investments	147.9M	104.31M	207.91M	n/a
Long-Term Investments	n/a	n/a	n/a	5.34M
Other Long-Term Assets	4.98M	4.93M	4.6M	n/a
Receivables	173K	505K	7.66M	n/a
Inventory	n/a	n/a	960K	n/a
Other Current Assets	5.12M	3.29M	4.44M	n/a
Total Current Assets	377.44M	236.21M	275.89M	348.67M
Property-Plant & Equipment	56.31M	62.61M	61.91M	12.32M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	61.29M	67.54M	66.5M	17.66M
Total Assets	438.73M	303.75M	342.39M	366.33M
Account Payables	17.21M	11.15M	7.86M	6.56M
Deferred Revenue	117.23M	17.68M	n/a	n/a
Short-Term Debt	n/a	n/a	3.13M	n/a
Other Current Liabilities	11.57M	9.26M	7.52M	840K
Total Current Liabilities	156.95M	46.59M	25.57M	16.64M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.7M	2.71M	1.53M	2.18M
Total Long-Term Liabilities	58.85M	77.91M	45.41M	2.18M
Total Liabilities	215.8M	124.5M	70.98M	18.81M
Total Debt	42.72M	46.04M	47M	n/a
Common Stock	6K	5K	5K	5K
Retained Earnings	-438.59M	-365.89M	-230.54M	-122.03M
Comprehensive Income	-3.36M	-2.72M	-1.75M	-2.02M
Shareholders Equity	222.94M	179.25M	271.41M	347.51M
Total Investments	147.9M	104.31M	207.91M	5.34M